Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents.
Buse
John B
JB
Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. jbuse@med.unc.edu
Sesti
Giorgio
G
Schmidt
Wolfgang E
WE
Montanya
Eduard
E
Chang
Cheng-Tao
CT
Xu
Yizhen
Y
Blonde
Lawrence
L
Rosenstock
Julio
J